Concepedia

Klaus‐Dieter Riedel

KR

34

Publications

1.9K

Citations

23

H-Index

1992

Active since

Affiliations

Heidelberg University(Current)

University Hospital Heidelberg

Heidelberg University

Karolinska Institutet

DSM (Austria)

Klaus‐Dieter Riedel is an author at Heidelberg University specializing in medicine, pharmacology, and drug analysis.

Top concepts

Publications per year

1992–2014

34

Publications

34

Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype

Ina M. Scholz, Heike Oberwittler, Klaus‐Dieter Riedel et al. · British Journal of Clinical Pharmacology · 2009 · 180 citations · Full text

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne et al. · British Journal of Clinical Pharmacology · 2003 · 144 citations · Full text

Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations

Eliford Ngaimisi, Abiy Habtewold, Omary Minzi et al. · PLoS ONE · 2013 · 124 citations · Full text

Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine

Germain Mandi, Boubacar Coulibaly, Steffen Witte et al. · Malaria Journal · 2006 · 121 citations · Full text

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

Getnet Yimer, Nobuhisa Ueda, Abiy Habtewold et al. · PLoS ONE · 2011 · 121 citations · Full text

Rows per page

1–5 of 34